|
|
Volumn 56, Issue SUPPL. 1, 1998, Pages 15-23
|
|
Rational assessment of the interaction profile of cerivastatin supports its low propensity for drug interactions
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALUMINUM MAGNESIUM HYDROXIDE;
ANTACID AGENT;
CERIVASTATIN;
CHOLESTEROL;
CIMETIDINE;
CLOFIBRATE;
COLESTYRAMINE;
CYTOCHROME P450;
DIGITOXIN;
DIGOXIN;
ERYTHROMYCIN;
FUROSEMIDE;
GEMFIBROZIL;
GLIBENCLAMIDE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
IBUPROFEN;
IMIPRAMINE;
ITRACONAZOLE;
MIBEFRADIL;
NICOTINIC ACID;
NIFEDIPINE;
OMEPRAZOLE;
PHENYLBUTAZONE;
PHENYTOIN;
PROPRANOLOL;
SALICYLIC ACID;
WARFARIN;
BILIARY EXCRETION;
CHOLESTEROL BLOOD LEVEL;
CONFERENCE PAPER;
DRUG ABSORPTION;
DRUG CLEARANCE;
DRUG EFFICACY;
DRUG METABOLISM;
DRUG PROTEIN BINDING;
DRUG TOLERABILITY;
HUMAN;
HYPERLIPIDEMIA;
MYOPATHY;
PATIENT COMPLIANCE;
PRACTICE GUIDELINE;
RHABDOMYOLYSIS;
URINARY EXCRETION;
ADULT;
ANTICHOLESTEREMIC AGENTS;
DRUG INTERACTIONS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
MALE;
PYRIDINES;
|
|
EID: 0031658907
PISSN: 00126667
EISSN: None
Source Type: Journal
DOI: 10.2165/00003495-199856001-00003 Document Type: Conference Paper |
|
Times cited : (66)
|
|
References (49)
|
